Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > NanoInk Announces Joint Research & Licensing Agreements with Prestigious Universities

Abstract:
NanoInk to collaborate with the UK Centre for Tissue Engineering at the University of Liverpool and the Centre of Molecular NanoMetrology at the University of Strathclyde

NanoInk Announces Joint Research & Licensing Agreements with Prestigious Universities

Skokie, IL | Posted on March 30th, 2009

NanoInk's NanoStem Cell Division announced today it has entered into joint research and licensing agreements with the UK Centre for Tissue Engineering (UKCTE) at the University of Liverpool in Liverpool, England, and the Centre of Molecular NanoMetrology at the University of Strathclyde in Glasgow, Scotland, for the development of modified surfaces for manipulation of stem cell differentiation. Dr. John Hunt at the UKCTE at the University of Liverpool and Dr. Duncan Graham at the Centre of Molecular NanoMetrology at the University of Strathclyde will act as principal investigators for the collaboration.

"We are extremely excited to join forces with these two esteemed institutions," said Jim Hussey, chief executive officer of NanoInk. "We are eager to pursue the commercial potential of using nanotechnology to control stem cell function, particularly in the area of regenerative medicine. Each organization brings a distinct area of expertise to the process and it is our hope that the knowledge we obtain through our collaborative approach will propel our stem cell application and capabilities in the area of regenerative medicine."

In January 2009, NanoInk launched the NanoStem Cell Division, which is aimed at providing a highly reliable, renewable source of differentiated adult stem cells. Leveraging NanoInk's proprietary Dip Pen Nanolithography® (DPN®) technology, it is now possible to produce differentiated homogenous stem cell populations which will lead to faster and more efficient drug discovery and development processes, with substantial cost savings. For more information about the NanoStem Cell Division, see www.nanoink.net/NanoStem_about.htm.

####

About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see www.nanoink.net.

NanoInk, the NanoInk logo, Dip Pen Nanolithography and DPN are trademarks or registered trademarks of NanoInk, Inc.

For more information, please click here

Contacts:
David Gutierrez
Dresner Corporate Services
312-780-7204


Jennifer Jameson
Dresner Corporate Services
312-780-7241

Copyright © NanoInk

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

Alliances/Trade associations/Partnerships/Distributorships

Manchester graphene spin-out signs $1billion game-changing deal to help tackle global sustainability challenges: Landmark deal for the commercialisation of graphene April 14th, 2023

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project